Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Research and development | 2.2 | 0.9 | 0.5 |
| General and administrative | 5.0 | 4.6 | 0.1 |
| EBIT | -7.2 | -5.6 | -0.6 |
| Pre-tax income | -10.2 | -7.8 | -0.6 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -10.2 | -9.3 | -0.6 |
| |
| Diluted EPS | ($1.53) | ($1.61) | ($0.11) |
| Shares outstanding (diluted) | 6.7 | 5.8 | 5.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|